subject: CHEBI:134716

subject_name: Brexpiprazole

object_name: anxiety


subject: CHEBI:134716

object_name: anxiety disorder

tested_intervention: yes


subject: CHEBI:134716

object_name: Anxiety symptoms


subject: CHEBI:134716

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:134716

object_name: Anxiety, CTCAE 5.0


subject: DRUGBANK:DB15020

subject_name: Mureletecan

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:6931

subject_name: Midazolam

object_name: Lumbar spondylosis


subject: CHEBI:6931

object_name: generalized anxiety


subject: CHEBI:17895

subject_name: Tyrosine

object_name: chronic kidney disease


subject: UMLS:C1446647

subject_name: Milk antigen

object_name: type 2 diabetes mellitus

tested_intervention: unsure


subject: UMLS:C1446647

object_name: cardiovascular disorder


subject: UMLS:C1446647

object_name: Systemic inflammatory response


subject: DRUGBANK:DB10543

subject_name: Cow milk


subject: DRUGBANK:DB10543


subject: DRUGBANK:DB10543


subject: UMLS:C0444318

subject_name: Milk Specimen


subject: UMLS:C0444318


subject: UMLS:C0444318


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: immune reconstitution inflammatory syndrome


subject: CHEBI:6888


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:64153

subject_name: Tanespimycin

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:64153

object_name: medullary thyroid gland carcinoma


subject: CHEBI:64153

object_name: Stage IV Thyroid Gland Papillary Carcinoma AJCC v7


subject: CHEBI:64153

object_name: Stage IV Thyroid Gland Follicular Carcinoma AJCC v7


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:93755


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: thyroid disease


subject: CHEBI:73604

object_name: parathyroid gland disorder


subject: PUBCHEM.COMPOUND:5289310

subject_name: AZILECT

object_name: Parkinson disease


subject: UMLS:C2757070

subject_name: Progesterone [EPC]

object_name: Luteal phase defect


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Multiple Trauma


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: generalized anxiety disorder


subject: CHEBI:18050

subject_name: L-Glutamine


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Drug toxicity


subject: CHEBI:10023

subject_name: Voriconazole

object_name: skin carcinoma


subject: UMLS:C5552948

subject_name: Clostridial Collagenase Ointment

object_name: decubitus ulcer


subject: UMLS:C5552948

object_name: Lower Limb Soft Tissue Necrotic Lesion


subject: UMLS:C5552948

object_name: Soft Tissue Necrosis Lower Limb, CTCAE


subject: CHEBI:7457

subject_name: Nalmefene

object_name: history of alcohol use


subject: CHEBI:7457

object_name: HIV infection


subject: UMLS:C0731178

subject_name: Madopar 250


subject: CHEBI:49668

subject_name: Gefitinib

object_name: peritoneal neoplasm


subject: CHEBI:63632

subject_name: Topotecan


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: Renal cancer metastatic


subject: UMLS:C5848866

object_name: Renal cancer recurrent


subject: UNII:X8T9SBH9LL

subject_name: DIQUAFOSOL TETRASODIUM

object_name: Dry Eye, CTCAE


subject: UNII:X8T9SBH9LL

object_name: Dryness of eye


subject: UMLS:C1880350

subject_name: diquafosol tetrasodium


subject: UMLS:C1880350


subject: PUBCHEM.COMPOUND:59311617

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:59311617

object_name: non-small cell lung carcinoma


subject: UMLS:C3896872

subject_name: Hsp90 Inhibitor DS-2248


subject: UMLS:C3896872


subject: UNII:3HJ2545H66


subject: UNII:3HJ2545H66


subject: UMLS:C2826357

subject_name: Beta-Glucan MM-10-001

object_name: lung cancer


subject: UMLS:C2826357

object_name: lung neoplasm


subject: UMLS:C2826357

object_name: lung carcinoma


subject: UMLS:C1881068

subject_name: intetumumab


subject: CHEBI:76777

subject_name: poly(inosinic acid)

object_name: influenza


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Shoulder pain


subject: CHEBI:4806

subject_name: Epigallocatechin gallate

object_name: fetal alcohol syndrome


subject: CHEBI:8382

subject_name: Prednisone

object_name: human coronavirus pneumonia


subject: DRUGBANK:DB05899

object_name: small cell lung carcinoma


subject: DRUGBANK:DB05899

object_name: prostate carcinoma


subject: DRUGBANK:DB05899

object_name: prostate cancer


subject: DRUGBANK:DB05899


subject: DRUGBANK:DB05899

object_name: urothelial carcinoma


subject: DRUGBANK:DB05899

object_name: transitional cell carcinoma


subject: CHEBI:681569

subject_name: Clofarabine

object_name: mantle cell lymphoma


subject: CHEBI:681569

object_name: follicular lymphoma


subject: CHEBI:681569

object_name: mature T-cell and NK-cell non-Hodgkin lymphoma


subject: CHEBI:681569

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: CHEBI:681569

object_name: lymphoplasmacytic lymphoma


subject: CHEBI:681569

object_name: Waldenstrom macroglobulinemia


subject: CHEBI:681569

object_name: marginal zone lymphoma


subject: CHEBI:681569

object_name: MALT lymphoma


subject: CHEBI:681569

object_name: anaplastic large cell lymphoma


subject: CHEBI:681569

object_name: angioimmunoblastic T-cell lymphoma


subject: UMLS:C1170277

subject_name: Flax Seed Oil

object_name: Hypercholesterolemia


subject: UMLS:C1170277

object_name: hyperlipidemia


subject: UMLS:C1170277

object_name: hyperlipoproteinemia


subject: UMLS:C1170277

object_name: Hyperlipidemia, CTCAE


subject: UMLS:C1170277

object_name: Serum lipids high (finding)


subject: CHEBI:46217

subject_name: L-alanine residue


subject: CHEBI:46217


subject: CHEBI:46217


subject: CHEBI:46217


subject: CHEBI:46217


subject: CHEBI:158283

subject_name: Ala-Leu-Ala


subject: CHEBI:158283


subject: CHEBI:158283


subject: CHEBI:158283


subject: CHEBI:158283


subject: CHEBI:16449

subject_name: DL-Alanine


subject: CHEBI:16449


subject: CHEBI:16449


subject: CHEBI:16449


subject: CHEBI:16449


subject: CHEBI:17549

subject_name: Aminolevulinic acid


subject: CHEBI:17549


subject: CHEBI:17549


subject: CHEBI:17549


subject: CHEBI:17549


subject: CHEBI:27432

subject_name: linolenic acid


subject: CHEBI:27432


subject: CHEBI:27432


subject: CHEBI:27432


subject: CHEBI:27432


subject: CHEBI:16977

subject_name: Alanine


subject: CHEBI:16977


subject: CHEBI:16977


subject: CHEBI:16977


subject: CHEBI:16977


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Rhinosinusitis


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Postimplantation syndrome


subject: CHEBI:41879

object_name: abdominal aortic aneurysm


subject: CHEBI:182913

subject_name: Dexpramipexole

object_name: Opioid withdrawal


subject: CHEBI:182913

object_name: opiate dependence


subject: CHEBI:182913

object_name: sleep disorder


subject: CHEBI:8356

subject_name: Pramipexole


subject: CHEBI:8356


subject: CHEBI:8356


subject: CHEBI:67272

subject_name: Perifosine

object_name: Myelodysplasia


subject: CHEBI:67272

object_name: adult lymphoma


subject: CHEBI:67272

object_name: lymphoma


subject: CHEBI:67272

object_name: pediatric lymphoma


subject: CHEBI:22652

subject_name: Ascorbic acid

object_name: Hyperlactatemia


subject: CHEBI:22652

object_name: bypass complications


subject: CHEBI:22652

object_name: heart disorder


subject: UNII:YNH9K62UXU

subject_name: EFAVALEUKIN ALFA

object_name: rheumatoid arthritis


subject: UMLS:C4687718

subject_name: Fc il-2 mutein fusion protein (amg-592)


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: refractory malignant neoplasm


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Hodgkin Disease


subject: CHEBI:48923

subject_name: erythromycin

object_name: preterm premature rupture of the membranes


subject: CHEBI:42355

subject_name: Erythromycin


subject: UMLS:C1456762

object_name: seborrheic keratosis


subject: CHEBI:201443


subject: UNII:7686S50JAH

subject_name: ingenol mebutate


subject: UMLS:C0972569

subject_name: Electrophoresis Gel


subject: UMLS:C1382104

subject_name: Gel physical state


subject: UMLS:C1551386

subject_name: Gel - ContainerSeparator


subject: UNII:CJN36EQM0H

subject_name: Pyrotinib

object_name: breast neoplasm


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Hand Injuries


subject: CHEBI:6888

object_name: Finger Injuries


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: Injury of bile duct


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:F40IRN5981

subject_name: Chiauranib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: CHEBI:187612

subject_name: Etalocib


subject: MESH:C094099


subject: CHEBI:64317

subject_name: Isoprenaline

object_name: ventricular arrhythmias due to cardiac ryanodine receptor calcium release deficiency syndrome


subject: CHEBI:64317

object_name: Adverse Event Associated with Cardiac Arrhythmia


subject: CHEBI:64317

object_name: Supraventricular arrhythmia


subject: CHEBI:64317

object_name: Supraventricular Arrhythmia by ECG Finding


subject: CHEBI:84040

object_name: diabetic kidney disease


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: UMLS:C2959235

subject_name: Injection, canakinumab, 1 mg administered

object_name: Metastatic Pancreatic Ductal Adenocarcinoma


subject: UMLS:C5203516

subject_name: Canakinumab Liquid Injection


subject: UNII:37CQ2C7X93

subject_name: Canakinumab


subject: GTOPDB:10140

subject_name: spartalizumab


subject: UNII:QOG25L6Z8Z


subject: UMLS:C4053607


subject: CHEBI:4875

subject_name: Etanercept

object_name: Pregnant


subject: PR:000001959

subject_name: tumor necrosis factor receptor superfamily member 1B


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: trabecular adenocarcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: cutaneous neuroendocrine carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: GTOPDB:9615


subject: GTOPDB:9615


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17530


subject: DRUGBANK:DB17530


subject: UNII:B0L24T8TB7


subject: UNII:B0L24T8TB7


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: UMLS:C5777124

subject_name: CD-16 NK-92 cells


subject: UMLS:C5777124


subject: UMLS:C4552849

subject_name: haNK


subject: UMLS:C4552849


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: PUBCHEM.COMPOUND:9831414

subject_name: Lovaza


subject: PUBCHEM.COMPOUND:9831414


subject: UNII:D87YGH4Z0Q

subject_name: Omacor


subject: UNII:D87YGH4Z0Q


subject: UMLS:C1384659

object_name: Neck Carcinoma


subject: UMLS:C1384659

object_name: head and neck neoplasm


subject: UMLS:C1384659

object_name: head and neck cancer


subject: UMLS:C0963149

subject_name: Definity

object_name: ovarian cancer


subject: UMLS:C0963149

object_name: ovarian neoplasm


subject: UMLS:C0963149

object_name: ovarian carcinoma


subject: CHEBI:31980

subject_name: Perflutren


subject: CHEBI:31980


subject: CHEBI:31980


subject: CHEBI:41948

subject_name: Eflornithine

object_name: bladder tumor


subject: CHEBI:41948

object_name: urinary bladder carcinoma


subject: CHEBI:41948

object_name: urinary bladder cancer


subject: CHEBI:41948

object_name: childhood bladder carcinoma


subject: UNII:68OJX9I7DT

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:824ZMS3BGL


subject: UMLS:C1101538


subject: UMLS:C3667888

subject_name: Trokendi XR

object_name: migraine


subject: UMLS:C3667888

object_name: migraine with or without aura, susceptibility to, 1


subject: UMLS:C3667888

object_name: Headache


subject: UMLS:C3667888

object_name: Headache, CTCAE


subject: PUBCHEM.COMPOUND:130770

object_name: cholecystitis


subject: PUBCHEM.COMPOUND:130770

object_name: Cholecystitis, CTCAE 3.0


subject: PUBCHEM.COMPOUND:130770

object_name: Cholecystitis, CTCAE 5.0


subject: PUBCHEM.COMPOUND:130770

object_name: acute cholecystitis


subject: CHEBI:8382

subject_name: Prednisone

object_name: COPD, severe early onset


subject: CHEBI:8382

object_name: obstructive lung disease


subject: UNII:F70C5K4786

subject_name: Melphalan flufenamide

object_name: AL amyloidosis


subject: UNII:3412470A0V

subject_name: melflufen


subject: GTOPDB:13086

subject_name: efanesoctocog alfa

object_name: von Willebrand disease (hereditary or acquired)


subject: UNII:WH7BHQ0RB4

subject_name: EFANESOCTOCOG ALFA


subject: UMLS:C5421030


subject: CHEMBL.COMPOUND:CHEMBL4650298

object_name: non-small cell lung carcinoma


subject: UMLS:C4725107

subject_name: ALK Inhibitor PLB 1003


subject: MESH:D022681

object_name: tetanus


subject: MESH:D022681

object_name: pertussis


subject: MESH:D022681

object_name: diphtheria


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: cellulitis


subject: CHEBI:6770

object_name: skin infection


subject: CHEBI:6770

object_name: Skin Infection, CTCAE


subject: CHEBI:6770

object_name: cellulitis on exam (physical finding)


subject: CHEBI:6770

object_name: abscess


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: pain measurement


subject: CHEBI:5855

subject_name: Ibuprofen


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Wilms tumor


subject: UNII:PVI5M0M1GW

object_name: childhood kidney Wilms tumor


subject: GTOPDB:4934

subject_name: G-CSF

object_name: nephroblastoma


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Viral gastroenteritis due to Rotavirus


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: UMLS:C1135142

subject_name: Metvix

object_name: basal cell carcinoma


subject: UMLS:C1135142

object_name: skin basal cell carcinoma


subject: UMLS:C1135142

object_name: Bowen's Disease


subject: CHEBI:724125

subject_name: Methyl aminolevulinate


subject: CHEBI:724125


subject: CHEBI:37845

subject_name: growth hormone

object_name: pituitary hormone deficiency, combined, 2


subject: CHEBI:37845

object_name: panhypopituitarism


subject: PUBCHEM.COMPOUND:170907453

subject_name: Growth hormone


subject: PUBCHEM.COMPOUND:170907453


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin


subject: UNII:NQX9KB6PCL


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0037663

subject_name: Growth Hormone


subject: UMLS:C0037663


subject: PR:000007968

subject_name: somatotropin


subject: PR:000007968


subject: GTOPDB:13396

subject_name: ivonescimab

object_name: rectal carcinoma


subject: GTOPDB:13396

object_name: rectal cancer


subject: GTOPDB:13396

object_name: Childhood Rectal Carcinoma


subject: GTOPDB:13396

object_name: Rash and Dermatitis Associated with Radiation Excluding Chemoradiation, CTCAE


subject: GTOPDB:13396

object_name: radiation exposure measurement


subject: UNII:Y0O332CU66

subject_name: IVONESCIMAB


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UNII:Y0O332CU66


subject: UMLS:C5669600

subject_name: Ivonescimab


subject: UMLS:C5669600


subject: DRUGBANK:DB16451

object_name: kidney failure


subject: CHEBI:8426

subject_name: Probenecid


subject: CHEBI:7862

subject_name: Oxymetazoline

object_name: ptosis


subject: CHEBI:7862

object_name: Eye Manifestations


subject: CHEBI:7862

object_name: conjunctivitis


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: Precocious atherosclerosis


subject: CHEBI:38545

object_name: CORONARY ARTERY DISEASE RISK FACTORS MULTIPLE


subject: CHEBI:38545

object_name: Coronary artery disease progression


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: Pandemic Disorder


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: CHEBI:50733

subject_name: nutraceutical

object_name: hypotrichosis


subject: CHEBI:50733

object_name: alopecia


subject: CHEBI:231087

subject_name: Trilaciclib

object_name: diffuse large B-cell lymphoma


subject: UMLS:C1366263

subject_name: Hyperimmune Colostrum, Bovine

object_name: HIV infection


subject: UMLS:C5447674

subject_name: Listeria monocytogenes-LLO-Prostate Cancer Neoantigens Vaccine ADXS-504

object_name: Prostate cancer recurrent


subject: UMLS:C4704764

object_name: Advanced cancer


subject: UMLS:C2729287

subject_name: INJECTION, TEMOZOLOMIDE, 1 MG, ADMINISTERED

object_name: melanoma


subject: UNII:5BSH2G9BH8

subject_name: Lucinactant

object_name: meconium aspiration syndrome


subject: CHEBI:6413

subject_name: Letrozole

object_name: lobular breast carcinoma in situ


subject: CHEBI:6413

object_name: healthy, no evidence of disease


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: cystic fibrosis


subject: UMLS:C3714501

object_name: glucose intolerance


subject: UMLS:C3714501

object_name: Glucose Intolerance, CTCAE


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:466659

object_name: lung cancer


subject: CHEBI:466659

object_name: lung neoplasm


subject: CHEBI:466659

object_name: lung carcinoma


subject: CHEBI:466659

object_name: unspecified adult solid tumor, protocol specific


subject: GTOPDB:12989

subject_name: toripalimab

object_name: High-Risk Cancer


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: CHEBI:31348

subject_name: Capecitabine


subject: UNII:TK62D59MXV

object_name: Stomach cancer


subject: UNII:TK62D59MXV

object_name: gastric cancer


subject: UNII:TK62D59MXV

object_name: Locally Advanced Gastric Adenocarcinoma


subject: UNII:TK62D59MXV

object_name: gastric neoplasm


subject: UMLS:C5855519

subject_name: Fluorine F 18 FAPI-74


subject: UMLS:C5855519


subject: MESH:C568072

subject_name: arepanrix

object_name: influenza


subject: UNII:349552KRHK

subject_name: Simendan

object_name: adult acute respiratory distress syndrome


subject: UNII:349552KRHK

object_name: Right Ventricular Dysfunction


subject: UNII:349552KRHK

object_name: Right Ventricular Dysfunction, CTCAE


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:193746


subject: CHEBI:50567

subject_name: Levosimendan


subject: CHEBI:50567


subject: CHEBI:50567


subject: UMLS:C0962969

subject_name: RAD 001

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C0962969

object_name: Embolism, Tumor


subject: DRUGBANK:DB14307

subject_name: Green tea leaf

object_name: postmenopausal disorder


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: Papulopustular Rosacea


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:66964

subject_name: Dronabinol

object_name: social phobia


subject: CHEBI:66964

object_name: generalized anxiety disorder


subject: CHEBI:66964

object_name: panic disorder


subject: CHEBI:66964

object_name: panic disorder 1


subject: CHEBI:66964

object_name: unreasonable fear being in open spaces or crossing bridges


subject: CHEBI:66964

object_name: agoraphobia


subject: CHEBI:74224

object_name: Cardiac amyloidosis


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:28088

subject_name: Genistein


subject: UNII:7UXW0T8LS8

object_name: mortality


subject: UNII:7UXW0T8LS8

object_name: adverse effect


subject: UMLS:C0032375

subject_name: Oral Poliovirus Vaccine


subject: CHEBI:27241

subject_name: methyl uridin-5-yloxyacetate


subject: CHEBI:27241


subject: CHEBI:73616

subject_name: Met-Val


subject: CHEBI:73616


subject: PR:000023306

object_name: Episodic migraine


subject: UniProtKB:P0AF12

subject_name: MTNN_ECOLI 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase (sprot)


subject: CHEBI:85974

subject_name: edoxaban tosylate hydrate

object_name: peripheral vascular disease


subject: CHEBI:85974

object_name: peripheral arterial disease


subject: PUBCHEM.COMPOUND:11635624

subject_name: Edoxaban


subject: PUBCHEM.COMPOUND:11635624


subject: UMLS:C1384659

object_name: Pleural effusion


subject: UMLS:C1384659

object_name: Pleural Effusion, CTCAE


subject: UMLS:C1384659

object_name: x-ray of chest: pleural effusion


subject: CHEBI:49960

subject_name: Vandetanib


subject: CHEBI:49960


subject: CHEBI:49960


subject: GTOPDB:4934

subject_name: G-CSF

object_name: coronary atherosclerosis


subject: CHEBI:70839

subject_name: Dasatinib

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:70839

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:70839

object_name: stage IIIB melanoma


subject: CHEBI:70839

object_name: stage IIIC melanoma


subject: CHEBI:70839

object_name: stage IIIA melanoma


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEBI:49375


subject: CHEMBL.COMPOUND:CHEMBL2109330

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: CHEMBL.COMPOUND:CHEMBL2109330

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: UMLS:C5417932

subject_name: IC 14


subject: UMLS:C5417932


subject: PUBCHEM.COMPOUND:6450536

object_name: Fatty Liver


subject: CHEBI:8378

subject_name: Prednisolone

object_name: chronic hepatitis B virus infection


subject: CHEBI:8378

object_name: hepatitis B


subject: CHEBI:60648

object_name: HIV infection


subject: PUBCHEM.COMPOUND:54671203


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: primary hyperparathyroidism


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2

object_name: Ischemic stroke


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: PUBCHEM.COMPOUND:5280374


subject: CHEBI:28869

subject_name: Menadione


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: CHEBI:16374

subject_name: Menatetrenone


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:27363

subject_name: Zinc


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: CHEBI:8802

subject_name: Remifentanil

object_name: overdose


subject: CHEBI:36939

subject_name: Fluorine F-18

object_name: neuroendocrine neoplasm


subject: CHEBI:36939

object_name: Neural crest tumor


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: undifferentiated connective tissue syndrome


subject: CHEBI:8382

subject_name: Prednisone


subject: PUBCHEM.COMPOUND:284240

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:284240

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:284240

object_name: breast cancer


subject: PUBCHEM.COMPOUND:284240

object_name: metastatic malignant neoplasm in the brain


subject: UNII:2X1K91UT6N

subject_name: Alovudine F-18


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UNII:2X1K91UT6N


subject: UMLS:C5447587

subject_name: Izastobart

object_name: Childhood Solid Neoplasm


subject: UMLS:C5447587

object_name: Adult Solid Neoplasm


subject: UMLS:C5447587

object_name: Solid Neoplasm


subject: UMLS:C5447587

object_name: Advanced cancer


subject: UMLS:C5447587

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5447587

object_name: Embolism, Tumor


subject: UMLS:C5447587

object_name: Neoplasm Metastasis


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: schizoaffective disorder


subject: UNII:1C6V77QF41

object_name: schizophrenia 18


subject: DRUGBANK:DB06336

subject_name: Elsiglutide

object_name: diarrhea


subject: DRUGBANK:DB06336

object_name: rectal discharge diarrhea (physical finding)


subject: DRUGBANK:DB06336

object_name: Diarrhea, CTCAE


subject: DRUGBANK:DB17468

subject_name: Odetiglucan

object_name: head and neck squamous cell carcinoma


subject: UMLS:C2698691

subject_name: Imprime PGG


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Locally Advanced Chordoma


subject: CHEBI:231614

object_name: Metastatic Chordoma


subject: CHEBI:231614

object_name: Unresectable Chordoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: chordoma


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C0150765

subject_name: Shampoo (substance)

object_name: folliculitis


subject: UMLS:C0150765

object_name: Folliculitis, CTCAE


subject: UMLS:C0150765

object_name: pityriasis simplex


subject: UMLS:C0150765

object_name: Dandruff


subject: CHEBI:35854

subject_name: Valaciclovir

object_name: Herpesviridae infectious disease


subject: CHEBI:5790

subject_name: Hydromorphone

object_name: Abdominal pain


subject: CHEBI:5790

object_name: Abdominal Pain, CTCAE


subject: UMLS:C4278474

object_name: diabetes mellitus


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Dyslipidemia


subject: UNII:55F75LJQ0V

subject_name: ANAMORELIN HYDROCHLORIDE

object_name: sarcopenia


subject: UNII:55F75LJQ0V

object_name: Osteopenia


subject: UMLS:C2346777

subject_name: RC-1291 HCl


subject: UMLS:C2346777


subject: UMLS:C4694434

subject_name: Palynziq

object_name: phenylketonuria


subject: CHEBI:84040

object_name: diabetic neuropathy


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: PUBCHEM.COMPOUND:156963654

subject_name: Sacituzumab govitecan

object_name: Transitional cell cancer of renal pelvis and ureter metastatic


subject: UNII:DA64T2C2IO

subject_name: SACITUZUMAB


subject: UMLS:C3640943


subject: UNII:5YV419FIJS

subject_name: sodium glycididazole

object_name: Metastatic urothelial carcinoma


subject: UNII:5YV419FIJS


subject: UNII:5YV419FIJS

object_name: urinary bladder carcinoma


subject: UNII:5YV419FIJS

object_name: urinary bladder cancer


subject: UNII:5YV419FIJS

object_name: childhood bladder carcinoma


subject: CHEBI:74814

subject_name: Ser-Gly


subject: CHEBI:74814


subject: CHEBI:74814


subject: CHEBI:74814


subject: CHEBI:74814


subject: CHEBI:33351

subject_name: seaborgium atom


subject: CHEBI:33351


subject: CHEBI:33351


subject: CHEBI:33351


subject: CHEBI:33351


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Stage II Childhood Burkitt Lymphoma


subject: CHEBI:61057

object_name: Stage III Childhood Burkitt Lymphoma


subject: CHEBI:61057

object_name: Stage I Childhood Burkitt Lymphoma


subject: CHEBI:61057

object_name: Stage IV Childhood Burkitt Lymphoma


subject: CHEBI:61057

object_name: Stage II Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:61057

object_name: Stage III Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:61057

object_name: Stage II Childhood Large Cell Lymphoma


subject: CHEBI:61057

object_name: Stage IV Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:61057

object_name: Stage I Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:61057

object_name: Stage III Childhood Large Cell Lymphoma


subject: CHEBI:61057

object_name: Stage IV Childhood Large Cell Lymphoma


subject: CHEBI:61057

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61057

object_name: Stage I Childhood Large Cell Lymphoma


subject: CHEBI:61057

object_name: Stage II Childhood Lymphoblastic Lymphoma


subject: CHEBI:61057

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61057

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61057

object_name: Stage III Childhood Lymphoblastic Lymphoma


subject: CHEBI:61057

object_name: Stage IV Childhood Lymphoblastic Lymphoma


subject: CHEBI:61057

object_name: Stage I Childhood Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage II Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage III Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage I Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage IV Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage II Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage III Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage II Childhood Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage IV Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage I Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage III Childhood Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage IV Childhood Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: PUBCHEM.COMPOUND:5372

object_name: Stage I Childhood Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage II Childhood Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: PUBCHEM.COMPOUND:5372

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: PUBCHEM.COMPOUND:5372

object_name: Stage III Childhood Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage IV Childhood Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Stage I Childhood Lymphoblastic Lymphoma


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: Stage II Childhood Burkitt Lymphoma


subject: CHEBI:61049

object_name: Stage III Childhood Burkitt Lymphoma


subject: CHEBI:61049

object_name: Stage I Childhood Burkitt Lymphoma


subject: CHEBI:61049

object_name: Stage IV Childhood Burkitt Lymphoma


subject: CHEBI:61049

object_name: Stage II Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:61049

object_name: Stage III Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:61049

object_name: Stage II Childhood Large Cell Lymphoma


subject: CHEBI:61049

object_name: Stage IV Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:61049

object_name: Stage I Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:61049

object_name: Stage III Childhood Large Cell Lymphoma


subject: CHEBI:61049

object_name: Stage IV Childhood Large Cell Lymphoma


subject: CHEBI:61049

object_name: Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61049

object_name: Stage I Childhood Large Cell Lymphoma


subject: CHEBI:61049

object_name: Stage II Childhood Lymphoblastic Lymphoma


subject: CHEBI:61049

object_name: Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61049

object_name: Stage IA Mycosis Fungoides and Sezary Syndrome AJCC v7


subject: CHEBI:61049

object_name: Stage III Childhood Lymphoblastic Lymphoma


subject: CHEBI:61049

object_name: Stage IV Childhood Lymphoblastic Lymphoma


subject: CHEBI:61049

object_name: Stage I Childhood Lymphoblastic Lymphoma


subject: CHEBI:134990

subject_name: Agomelatine

object_name: Negative symptoms in schizophrenia


subject: UMLS:C3641657

subject_name: CEND 1

object_name: Metastatic malignant neoplasm to pancreas


subject: UNII:E628ZH6U2C

object_name: B-cell chronic lymphocytic leukemia


subject: UNII:E628ZH6U2C

object_name: B-cell non-Hodgkin lymphoma


subject: UNII:E628ZH6U2C

object_name: B-cell neoplasm


subject: UNII:QY50S617NM


subject: UNII:QY50S617NM


subject: UNII:QY50S617NM


subject: UMLS:C2348995


subject: UMLS:C2348995


subject: UMLS:C2348995


subject: UNII:4T36H88UA7

subject_name: Apalutamide

object_name: Low risk of recurrence, prostate cancer (PRCA)


subject: CHEBI:3892

subject_name: Corticotropin

object_name: kidney disorder


subject: UMLS:C5201181

subject_name: H.P. acthar gel


subject: UMLS:C5706432

subject_name: WT1-targeted IL-2-based Fusion Protein CUE-102

object_name: pancreatic neoplasm


subject: UMLS:C5706432

object_name: exocrine pancreatic carcinoma


subject: UMLS:C5706432

object_name: malignant pancreatic neoplasm


subject: UMLS:C5706432

object_name: Stomach cancer


subject: UMLS:C5706432

object_name: gastric cancer


subject: UMLS:C5706432

object_name: ovarian cancer


subject: UMLS:C5706432

object_name: ovarian neoplasm


subject: UMLS:C5706432

object_name: ovarian carcinoma


subject: UMLS:C5706432

object_name: colorectal cancer


subject: UMLS:C5706432

object_name: colorectal carcinoma


subject: UMLS:C5706432

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:5372

object_name: psoriasis vulgaris


subject: UMLS:C0718690

subject_name: Aspirin Enteric Coated

object_name: pulmonary embolism


subject: UMLS:C0718690

object_name: thrombophilia due to thrombin defect


subject: UMLS:C0718690

object_name: Venous thrombosis after immobility


subject: CHEBI:60802

subject_name: ropivacaine

object_name: atrial fibrillation


subject: CHEBI:60802

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:60802

object_name: Atrial Fibrillation, CTCAE


subject: PUBCHEM.COMPOUND:71740

subject_name: CAFEDRINE

object_name: brain ischemia


subject: PUBCHEM.COMPOUND:71740

object_name: cerebral infarction


subject: CHEBI:135580

subject_name: Theodrenaline


subject: CHEBI:135580


subject: CHEBI:32278

subject_name: Urapidil


subject: CHEBI:32278


subject: CHEBI:4356

subject_name: Deferoxamine

object_name: Unresectable Hepatocellular Carcinoma


subject: CHEBI:8802

subject_name: Remifentanil

object_name: Cerebral Blood Flow


subject: CHEBI:8802

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: CHEBI:63617

subject_name: Pergolide

object_name: schizophrenia


subject: CHEBI:4495

subject_name: Diazoxide

object_name: Glucose metabolism disorders (incl diabetes mellitus)


subject: CHEBI:7986

subject_name: Pentoxifylline

object_name: Behçet's disease affecting oral mucosa


subject: UMLS:C1268551

subject_name: Echinocandins

object_name: peritonitis


subject: UMLS:C1268551

object_name: septic shock


subject: CHEMBL.COMPOUND:CHEMBL183041

subject_name: Tipranavir

object_name: chronic hepatitis C virus infection


subject: UMLS:C4723950

subject_name: pork extract

object_name: rhinitis


subject: UMLS:C4723950

object_name: Rhinoconjunctivitis


subject: UMLS:C4723950

object_name: Uncontrolled asthma


subject: UMLS:C4723950

object_name: Allergic rhinoconjunctivitis


subject: DRUGBANK:DB10561

subject_name: Pork


subject: DRUGBANK:DB10561


subject: DRUGBANK:DB10561


subject: DRUGBANK:DB10561


subject: CHEBI:71223

subject_name: Pralatrexate

object_name: lung cancer


subject: CHEBI:71223

object_name: lung neoplasm


subject: CHEBI:71223

object_name: lung carcinoma


subject: CHEBI:4471

subject_name: dextromethorphan hydrobromide

object_name: abortion in first trimester


subject: CHEBI:146178

subject_name: RACEMETHORPHAN


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: PR:000016622

subject_name: tRNA (cytosine-5-)-methyltransferase

object_name: infectious disease


subject: PR:000016622

object_name: Antibiotic resistant infection


subject: PR:000016622

object_name: Gram-negative bacteraemia


subject: UMLS:C1951572

subject_name: Flovent Diskus

object_name: asthma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Uveal Melanoma Metastatic in the Liver


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UNII:AF75XOF6W3

subject_name: Relatlimab


subject: UMLS:C3827149


subject: UMLS:C2348637

subject_name: TLR9 Agonist SD-101


subject: PUBCHEM.COMPOUND:163196420

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:163196420

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:163196420

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:163196420

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:163196420

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:163196420

object_name: Relapse multiple myeloma


subject: PUBCHEM.COMPOUND:163196420

object_name: Plasma cell myeloma recurrent


subject: UMLS:C5666991

subject_name: SETD2 Inhibitor EZM0414


subject: UMLS:C5666991


subject: UMLS:C5666991


subject: UMLS:C5666991


subject: UMLS:C5666991


subject: UMLS:C5666991


subject: UMLS:C5666991


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: prostate neoplasm


subject: CHEBI:77572

subject_name: Tranilast

object_name: sarcoidosis


subject: CHEBI:77572

object_name: sarcoidosis, susceptibility to, 1


subject: CHEBI:75551

object_name: sickle cell disease


subject: CHEBI:75551

object_name: sickle cell-hemoglobin c disease syndrome


subject: CHEBI:75551

object_name: sickle cell-beta-thalassemia disease syndrome


subject: CHEBI:75551

object_name: Sickle cell-thalassemia disease


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: CHEBI:74705


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:75958

subject_name: solution


subject: CHEBI:75958


subject: CHEBI:75958


subject: CHEBI:75958


subject: UMLS:C0037633

subject_name: Solutions


subject: UMLS:C0037633


subject: UMLS:C0037633


subject: UMLS:C0037633


subject: UMLS:C0042210

subject_name: Vaccines

object_name: shigellosis


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:74705


subject: PR:000009425


subject: PR:000016318


subject: CHEBI:61080

subject_name: Romidepsin

object_name: Stage IV adult soft tissue sarcoma


subject: CHEBI:61080

object_name: stage III adult soft tissue sarcoma


subject: CHEBI:61080

object_name: Adult Synovial Sarcoma


subject: CHEBI:61080

object_name: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor


subject: CHEBI:61080

object_name: adult liposarcoma


subject: CHEBI:61080

object_name: adult epithelioid sarcoma


subject: CHEBI:61080

object_name: alveolar soft part sarcoma


subject: CHEBI:61080

object_name: adult fibrosarcoma


subject: CHEBI:61080

object_name: Adult Angiosarcoma


subject: CHEBI:61080

object_name: Recurrent tumors of the Ewing's family


subject: CHEBI:61080

object_name: Adult Leiomyosarcoma


subject: CHEBI:61080

object_name: Adult Rhabdomyosarcoma


subject: CHEBI:61080

object_name: adult malignant schwannoma


subject: CHEBI:61080

object_name: adult myxoid chondrosarcoma


subject: CHEBI:61080

object_name: Plexosarcoma


subject: CHEBI:61080

object_name: adult extraskeletal osteosarcoma


subject: CHEBI:61080

object_name: undifferentiated pleomorphic sarcoma


subject: CHEBI:61080

object_name: adult malignant hemangiopericytoma


subject: CHEBI:61080

object_name: adult malignant mesenchymoma


subject: UMLS:C0963679

object_name: Stage IV adult soft tissue sarcoma


subject: UMLS:C0963679

object_name: stage III adult soft tissue sarcoma


subject: UMLS:C0963679

object_name: Adult Synovial Sarcoma


subject: UMLS:C0963679

object_name: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor


subject: UMLS:C0963679

object_name: adult liposarcoma


subject: UMLS:C0963679

object_name: adult epithelioid sarcoma


subject: UMLS:C0963679

object_name: alveolar soft part sarcoma


subject: UMLS:C0963679

object_name: adult fibrosarcoma


subject: UMLS:C0963679

object_name: Adult Angiosarcoma


subject: UMLS:C0963679

object_name: Recurrent tumors of the Ewing's family


subject: UMLS:C0963679

object_name: Adult Leiomyosarcoma


subject: UMLS:C0963679

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C0963679

object_name: adult malignant schwannoma


subject: UMLS:C0963679

object_name: adult myxoid chondrosarcoma


subject: UMLS:C0963679

object_name: Plexosarcoma


subject: UMLS:C0963679

object_name: adult extraskeletal osteosarcoma


subject: UMLS:C0963679

object_name: undifferentiated pleomorphic sarcoma


subject: UMLS:C0963679

object_name: adult malignant hemangiopericytoma


subject: UMLS:C0963679

object_name: adult malignant mesenchymoma


subject: CHEBI:93772

subject_name: Ispinesib

object_name: liver cancer


subject: CHEBI:93772

object_name: liver neoplasm


subject: CHEBI:93772

object_name: Adult Liver Carcinoma


subject: CHEBI:93772

object_name: liver carcinoma


subject: CHEBI:75832

subject_name: ferrous sulfate

object_name: Dyssomnias


subject: UMLS:C0085980

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:27732

subject_name: Caffeine

object_name: Post-Dural Puncture Headaches


subject: CHEBI:27732

object_name: Lumbar Puncture Headache


subject: PUBCHEM.COMPOUND:170128935

subject_name: Olomorasib

object_name: liver failure


subject: UNII:C2VJ83PSN7

subject_name: OLOMORASIB


subject: CHEBI:42797

subject_name: Gabapentin

object_name: puerperal disorder


subject: CHEBI:42797

object_name: chronic pain syndrome


subject: UNII:HX0VO60T62

subject_name: NSI-189 PHOSPHATE

object_name: Depressed mood


subject: UNII:HX0VO60T62

object_name: Cancer patients and suicide and depression


subject: UNII:HX0VO60T62

object_name: Depressed - symptom


subject: UNII:HX0VO60T62

object_name: Depression, CTCAE


subject: UMLS:C4507671

subject_name: NSI-189 phosphate


subject: UMLS:C4507671


subject: UMLS:C4507671


subject: UMLS:C4507671


subject: CHEBI:8499

subject_name: Propranolol

object_name: bladder tumor


subject: CHEBI:8499

object_name: urinary bladder carcinoma


subject: CHEBI:8499

object_name: urinary bladder cancer


subject: CHEBI:8499

object_name: childhood bladder carcinoma


subject: CHEBI:32297

subject_name: Vinpocetine

object_name: fetal alcohol spectrum disorder


subject: CHEBI:32297

object_name: fetal alcohol syndrome


subject: CHEBI:91571


subject: CHEBI:91571


subject: UNII:2Z03364G96

subject_name: Dapansutrile

object_name: Primary gout


subject: UNII:2Z03364G96

object_name: Gout flare


subject: UNII:2Z03364G96

object_name: gout


subject: UNII:2Z03364G96

object_name: Gout attack


subject: UNII:2Z03364G96

object_name: Arthralgia


subject: UNII:2Z03364G96

object_name: Joint Pain, CTCAE


subject: UNII:2Z03364G96

object_name: arthritis


subject: UNII:2Z03364G96

object_name: Arthritis, CTCAE


subject: CHEBI:51788

subject_name: faropenem

object_name: bacterial pneumonia


subject: PUBCHEM.COMPOUND:49865963

subject_name: TRABECTEDIN

object_name: Chronic lymphocytic leukaemia refractory


subject: PUBCHEM.COMPOUND:49865963

object_name: B-cell small lymphocytic lymphoma refractory


subject: PUBCHEM.COMPOUND:3199

subject_name: ecteinascidin 743


subject: PUBCHEM.COMPOUND:3199


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Inflammation


subject: UMLS:C1506837

object_name: bladder tumor


subject: UMLS:C1506837

object_name: urinary bladder carcinoma


subject: UMLS:C1506837

object_name: urinary bladder cancer


subject: UMLS:C1506837

object_name: childhood bladder carcinoma


subject: CHEBI:63587

subject_name: Eribulin


subject: CHEBI:63587


subject: CHEBI:63587


subject: CHEBI:63587


subject: UNII:N824AOU5XV

subject_name: Pegvisomant

object_name: polyostotic fibrous dysplasia


subject: UNII:N824AOU5XV

object_name: McCune-Albright syndrome


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: Headache


subject: CHEBI:6950

object_name: Headache, CTCAE


subject: UNII:H57D26Z9YK

subject_name: remestemcel-l

object_name: ulcerative colitis


subject: UNII:H57D26Z9YK

object_name: inflammatory bowel disease 1


subject: DRUGBANK:DB18032

subject_name: Allogenic bone marrow-derived mesenchymal stem cells


subject: DRUGBANK:DB18032


subject: CHEBI:6801

subject_name: Metformin

object_name: Suppressed lactation


subject: CHEBI:9168

subject_name: Sirolimus

object_name: primary antiphospholipid syndrome


subject: CHEBI:28645

subject_name: FRUCTOSE

object_name: metabolic disease


subject: CHEBI:28645

object_name: disorder of fructose metabolism


subject: CHEBI:48095

subject_name: keto-D-fructose


subject: CHEBI:48095


subject: CHEBI:499361

subject_name: Aprepitant

object_name: post-traumatic stress disorder


subject: CHEBI:17061

subject_name: D-Glutamine

object_name: pneumonia


subject: CHEBI:17061

object_name: COVID-19-Associated Pneumonia


subject: CHEBI:17061

object_name: Oral Mucositis


subject: CHEBI:17061

object_name: stomatitis


subject: CHEBI:17061

object_name: oral mucositis


subject: CHEBI:28300

subject_name: glutamine


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:28300


subject: CHEBI:18050

subject_name: L-Glutamine


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: CHEBI:18050


subject: RXCUI:8375

subject_name: placebo Oral Tablet

object_name: Impulsivity


subject: RXCUI:8375

object_name: Apathy


subject: RXCUI:8375

object_name: On examination - apathetic


subject: CHEBI:6887

subject_name: Methylphenidate


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: marginal zone lymphoma of mucosa-associated lymphoid tissue


subject: UNII:52CMI0WC3Y

object_name: marginal zone lymphoma


subject: UNII:52CMI0WC3Y

object_name: MALT lymphoma


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UMLS:C3827082


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:2948

subject_name: Azathioprine

object_name: Acute graft rejection


subject: CHEBI:2948

object_name: Delayed Graft Function


subject: CHEBI:9168


subject: UMLS:C0731433

subject_name: Haelan

object_name: Anorexia


subject: UMLS:C0731433

object_name: Anorexia, CTCAE


subject: UMLS:C0731433

object_name: Anorexia symptom


subject: UMLS:C0731433

object_name: Cachexia


subject: UMLS:C0731433

object_name: Weight loss


subject: UMLS:C0731433

object_name: Weight Loss, CTCAE


subject: CHEBI:5127

subject_name: Flurandrenolide


subject: CHEBI:5127


subject: CHEBI:5127


subject: CHEBI:5127


subject: CHEBI:5127


subject: CHEBI:5127


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin

object_name: plantar wart


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: UNII:LKC0U3A8NJ

subject_name: Evolocumab


subject: UMLS:C5706442

subject_name: Anti-ILT2 Monoclonal Antibody AGEN1571

object_name: Advanced Malignant Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: UMLS:C4764272

subject_name: Botensilimab


subject: CHEBI:70746

subject_name: Dabigatran etexilate

object_name: Minor ischaemic stroke


subject: CHEBI:70746

object_name: transient ischemic attack


subject: CHEBI:70752

subject_name: Dabigatran


subject: CHEBI:70752


subject: UMLS:C0017302

subject_name: General anesthetic drugs

object_name: Surgical procedure finding


subject: UMLS:C3536928

subject_name: General Anesthetic [EPC]


subject: UNII:XQJ55R5PPQ

object_name: neoplasm


subject: UMLS:C4287710

subject_name: Fluorescent Antibody SGM-101

object_name: Mild dysplasia of colon


subject: UMLS:C4287710

object_name: IMAGe syndrome


subject: UMLS:C0015506

subject_name: factor VIII

object_name: hematologic disorder


subject: UMLS:C0015506

object_name: blood coagulation disease


subject: UMLS:C0015506

object_name: inherited bleeding disorder, platelet-type


subject: UMLS:C0015506

object_name: blood platelet disease


subject: CHEBI:124917

subject_name: Rabusertib

object_name: pancreatic neoplasm


subject: UNII:C9J89787U1

object_name: interstitial lung disease 1


subject: UNII:C9J89787U1

object_name: interstitial lung disease 2


subject: UNII:C9J89787U1

object_name: Cough


subject: UNII:C9J89787U1

object_name: Cough, CTCAE


subject: UNII:C9J89787U1

object_name: Fibrotic lung disease


subject: UNII:C9J89787U1

object_name: pulmonary fibrosis


subject: UNII:C9J89787U1

object_name: idiopathic interstitial pneumonia


subject: UNII:C9J89787U1

object_name: Chronic cough


subject: CHEBI:32172

subject_name: suplatast


subject: CHEBI:32172


subject: CHEBI:32172


subject: CHEBI:32172


subject: CHEBI:32172


subject: CHEBI:32172


subject: CHEBI:32172


subject: CHEBI:32172


subject: CHEBI:80961

object_name: Stage III Rectal Cancer AJCC v6


subject: UNII:8M7YSN2KII

subject_name: nortramadol


subject: CHEBI:51112


subject: CHEBI:34827


subject: CHEMBL.COMPOUND:CHEMBL4525134


subject: UniProtKB:P15379-4

subject_name: CD44 antigen isoform 4 (mouse)


subject: CHEBI:7465

subject_name: Naltrexone

object_name: kleptomania


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: ankylosing spondylitis


subject: CHEBI:10023

subject_name: Voriconazole

object_name: adult lymphoma


subject: CHEBI:10023

object_name: lymphoma


subject: CHEBI:10023

object_name: pediatric lymphoma


subject: CHEBI:63451

subject_name: Infigratinib

object_name: central nervous system neoplasm


subject: CHEBI:63451

object_name: central nervous system cancer


subject: CHEBI:63451

object_name: Recurrent WHO Grade 2 Glioma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Locally Recurrent Rectal Carcinoma


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:46345

subject_name: Fluorouracil


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UMLS:C0879636

subject_name: IMC C225


subject: CHEBI:80630

subject_name: Irinotecan


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: UMLS:C5557417

subject_name: Enlonstobart


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: type 1 diabetes mellitus


subject: CHEBI:50885

subject_name: Fludrocortisone


subject: CHEBI:3223

subject_name: Buspirone

object_name: Williams syndrome


subject: CHEBI:8871

subject_name: Risperidone


subject: PUBCHEM.COMPOUND:25476

subject_name: Angiotensina II

object_name: Vasodilatory shock


subject: CHEBI:2719

subject_name: Angiotensin II


subject: PR:000036009

subject_name: angiotensin II


subject: UMLS:C5400662

subject_name: Therapeutic Angiotensin II


subject: UNII:8K80YB5GMG

subject_name: Rilonacept

object_name: Still Disease


subject: UMLS:C2343505

subject_name: Arcalyst


subject: CHEBI:46662

subject_name: mineral

object_name: Stress


subject: CHEBI:46662

object_name: anxiety


subject: CHEBI:46662

object_name: anxiety disorder


subject: CHEBI:46662

object_name: Anxiety symptoms


subject: CHEBI:46662

object_name: Anxiety, CTCAE 3.0


subject: CHEBI:46662

object_name: Anxiety, CTCAE 5.0


subject: CHEBI:18145

subject_name: Vitamin E


subject: UMLS:C3540032

subject_name: Vitamin IV solution additives


subject: UMLS:C3540032


subject: UMLS:C3540032


subject: UMLS:C3540032


subject: UMLS:C3540032


subject: UMLS:C3540032


subject: UMLS:C3714649

subject_name: VITAMINS [VA Class]


subject: UMLS:C3714649


subject: UMLS:C3714649


subject: UMLS:C3714649


subject: UMLS:C3714649


subject: UMLS:C3714649


subject: UMLS:C2698128

object_name: Hodgkin Disease


subject: CHEBI:36005

subject_name: docosahexaenoic acid

object_name: sclerosing cholangitis


subject: CHEBI:36005

object_name: primary sclerosing cholangitis


subject: CHEBI:36005

object_name: colitis


subject: CHEBI:36005

object_name: Colitis, CTCAE


subject: CHEBI:28125

subject_name: Doconexent


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:28125


subject: CHEBI:16016

subject_name: Glycerone


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:16016


subject: CHEBI:28689

subject_name: Prasterone


subject: CHEBI:28689


subject: CHEBI:28689


subject: CHEBI:28689


subject: UNII:59XC9G796Y

object_name: Alzheimer disease type 1


subject: UNII:59XC9G796Y

object_name: Alzheimer disease


subject: UMLS:C0392939

subject_name: recombinant human thrombopoietin

object_name: pulmonary fibrosis and/or bone marrow failure, Telomere-related, 2


subject: UMLS:C0392939

object_name: idiopathic aplastic anemia


subject: CHEBI:8713

subject_name: Quinapril

object_name: Menopause present (finding)


subject: CHEBI:8713

object_name: Menopause


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Cough suppression


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:32599


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:64816

object_name: Childhood Large Cell Lymphoma


subject: CHEBI:64816

object_name: reticulosarcoma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:3770

subject_name: co-trimoxazole


subject: CHEBI:3770


subject: CHEBI:3770

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:3770

object_name: non-Hodgkin lymphoma


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: CHEBI:31355

subject_name: Carboplatin


subject: CHEBI:31355


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:41879


subject: CHEBI:8382

subject_name: Prednisone


subject: CHEBI:8382


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:93775


subject: CHEBI:50681


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:44185


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:27375

subject_name: Vinblastine


subject: CHEBI:27375


subject: CHEBI:27375


subject: CHEBI:27375


subject: UMLS:C5706360

subject_name: ATR Inhibitor IMP9064

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5706360

object_name: Childhood Solid Neoplasm


subject: UMLS:C5706360

object_name: Adult Solid Neoplasm


subject: UMLS:C5706360

object_name: Solid Neoplasm


subject: PUBCHEM.COMPOUND:123812

subject_name: heliox

object_name: Premature infant


subject: PUBCHEM.COMPOUND:123812

object_name: congenital alveolar dysplasia


subject: PUBCHEM.COMPOUND:123812

object_name: respiratory distress syndrome in premature infants


subject: PUBCHEM.COMPOUND:123812

object_name: newborn respiratory distress syndrome


subject: CHEBI:3441

subject_name: Carvedilol

object_name: end stage renal failure


subject: CHEBI:3441

object_name: Chronic uremia


subject: PUBCHEM.COMPOUND:9800288

subject_name: METOPROLOL SUCCINATE


subject: PUBCHEM.COMPOUND:9800288


subject: CHEBI:6904

subject_name: Metoprolol


subject: UMLS:C1873351

object_name: sleep disorder


subject: CHEBI:134709

subject_name: Pitolisant


subject: CHEBI:9356

subject_name: Sultopride

object_name: Compulsion


subject: CHEBI:64045

subject_name: Amisulpride


subject: CHEBI:567361

subject_name: Cladribine

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:567361

object_name: chronic myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: history of alcohol use


subject: UMLS:C0592155

subject_name: Syntocinon


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Malignant neoplasm of female breast


subject: PUBCHEM.COMPOUND:1805

object_name: invasive breast carcinoma


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: UMLS:C0873126

subject_name: borage extract

object_name: asthma


subject: UMLS:C1256263

subject_name: Borago officinalis, flower essence


subject: UMLS:C0730970

subject_name: Creon 25000

object_name: exocrine pancreatic insufficiency


subject: CHEBI:231614

subject_name: Nivolumab

object_name: Non-clear cell renal cell carcinoma


subject: UMLS:C2346820


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib


subject: UMLS:C5205927


subject: UMLS:C0073384

subject_name: Ringer's acetate

object_name: Abnormality of temperature regulation


subject: UMLS:C0073384

object_name: Hypovolemia


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Iron absorption level


subject: UNII:MR86K0XRQP

subject_name: Dotap

object_name: lung cancer


subject: UNII:MR86K0XRQP

object_name: lung neoplasm


subject: UNII:MR86K0XRQP

object_name: lung carcinoma


subject: CHEBI:17026

subject_name: Progesterone

object_name: Exercise-related amenorrhea


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: CHEBI:7640

subject_name: Nortriptyline

object_name: endogenous depression


subject: CHEBI:7640

object_name: melancholia


subject: CHEBI:9123

subject_name: Sertraline


subject: CHEMBL.COMPOUND:CHEMBL4650410

subject_name: NOVAFERON

object_name: neuroendocrine neoplasm


subject: UMLS:C3273450

subject_name: Novaferon


subject: CHEBI:52010

subject_name: chlorphenamine

object_name: Allergy


subject: CHEBI:72297

subject_name: Lomitapide

object_name: Pregnant


subject: CHEBI:132774

subject_name: Roxadustat

object_name: liver failure


subject: UMLS:C3713379


subject: CHEBI:3286

subject_name: Cabergoline

object_name: cocaine dependence


subject: CHEBI:3286

object_name: Harmful pattern of substance use


subject: CHEBI:3286

object_name: substance abuse


subject: CHEBI:83279

subject_name: IODOCARB

object_name: myalgic encephalomeyelitis/chronic fatigue syndrome


subject: CHEBI:188591

subject_name: Naveglitazar

object_name: type 2 diabetes mellitus


subject: CHEBI:15379

subject_name: Oxygen

object_name: inflammatory bowel disease


subject: UMLS:C2699335

subject_name: cixutumumab

object_name: head and neck squamous cell carcinoma


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Early Stage Triple-Negative Breast Carcinoma


subject: CHEBI:231679

object_name: Unresectable Triple-Negative Breast Carcinoma


subject: CHEBI:231679

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: CHEBI:231679

object_name: Locally Advanced Triple-Negative Breast Carcinoma


subject: CHEBI:231679

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:231679

object_name: Breast cancer recurrent


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: UNII:C3059TG1KN

object_name: ovarian cancer


subject: UNII:C3059TG1KN

object_name: ovarian neoplasm


subject: UNII:C3059TG1KN

object_name: ovarian carcinoma


subject: UMLS:C3640995

subject_name: Kevetrin


subject: UMLS:C3640995


subject: UMLS:C3640995


subject: UMLS:C4763660

subject_name: Troxacitabine nucleotide prodrug miv-818

object_name: Metastatic malignant neoplasm to liver


subject: UMLS:C4763660

object_name: intrahepatic cholangiocarcinoma


subject: UMLS:C4763660

object_name: liver carcinoma


subject: PUBCHEM.COMPOUND:118910542


subject: PUBCHEM.COMPOUND:118910542


subject: PUBCHEM.COMPOUND:118910542


subject: UNII:Q1I6YZ0NGF

subject_name: Fostroxacitabine bralpamide


subject: UNII:Q1I6YZ0NGF


subject: UNII:Q1I6YZ0NGF


subject: CHEBI:134964

subject_name: Perflubutane

object_name: Renal transplant rejection


subject: MESH:C069727

subject_name: Sonazoid


subject: UMLS:C4725074

subject_name: HER2-targeted DARPin MP0274

object_name: neoplasm


subject: UNII:4RA0KN46E0

subject_name: Upadacitinib

object_name: autoimmune thrombocytopenia


subject: UNII:4RA0KN46E0

object_name: thrombocytopenia due to immune destruction


subject: UNII:4RA0KN46E0

object_name: autoimmune thrombocytopenic purpura


subject: CHEMBL.COMPOUND:CHEMBL4594480

object_name: pancreatic neoplasm


subject: CHEMBL.COMPOUND:CHEMBL4594480

object_name: exocrine pancreatic carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4594480

object_name: malignant pancreatic neoplasm


subject: UMLS:C3896827

subject_name: Anti-CEACAM6 AFAIKL2 Antibody Fragment/Jack Bean Urease Immunoconjugate L-DOS47


subject: UMLS:C3896827


subject: UMLS:C3896827


subject: CHEBI:2549

subject_name: Albuterol

object_name: Tachycardia


subject: UMLS:C2987725

object_name: Relapsed/refractory multiple myeloma


subject: UMLS:C4733695

subject_name: Anti-LAG-3 Monoclonal Antibody Sym022

object_name: adult lymphoma


subject: UMLS:C4733695

object_name: lymphoma


subject: UMLS:C4733695

object_name: pediatric lymphoma


subject: CHEBI:167672

subject_name: Tovorafenib

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5417847

subject_name: Aryl Hydrocarbon Receptor Inhibitor IK-175

object_name: Childhood Solid Neoplasm


subject: UMLS:C5417847

object_name: Adult Solid Neoplasm


subject: UMLS:C5417847

object_name: Solid Neoplasm


subject: UMLS:C5417847

object_name: urothelial carcinoma


subject: UMLS:C5417847

object_name: transitional cell carcinoma


subject: UMLS:C5417847

object_name: Locally Advanced Malignant Solid Neoplasm


subject: UMLS:C5417847

object_name: Metastatic urothelial carcinoma


subject: UMLS:C5417847


subject: UMLS:C5417847

object_name: bladder transitional cell carcinoma


subject: UMLS:C5417847

object_name: Solid carcinoma


subject: UMLS:C5417847

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5417847

object_name: Embolism, Tumor


subject: UMLS:C5417847

object_name: Neoplasm Metastasis


subject: UMLS:C5417847

object_name: Advanced cancer


subject: UMLS:C5417847

object_name: urothelial neoplasm


subject: UMLS:C5417847

object_name: bladder disease


subject: UMLS:C5417847

object_name: Reported prior bladder disease


subject: UMLS:C5417847

object_name: Bladder cancer stage IV


subject: UMLS:C5417847

object_name: bladder tumor


subject: UMLS:C5417847

object_name: cancer


subject: UMLS:C5417847

object_name: urinary bladder carcinoma


subject: UMLS:C5417847

object_name: urinary bladder cancer


subject: UMLS:C5417847

object_name: childhood bladder carcinoma


subject: UMLS:C5417847

object_name: neoplasm


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C0722908

subject_name: Pulmicort Turbuhaler

object_name: pneumonitis


subject: UMLS:C0722908

object_name: Pneumonitis, CTCAE


subject: UMLS:C0722908

object_name: immune-mediated adverse reaction


subject: CHEBI:8081

subject_name: Phentolamine

object_name: Acute kidney injury following administration of contrast media


subject: CHEBI:8081

object_name: acute coronary syndrome


subject: CHEBI:8081

object_name: coronary artery disorder


subject: CHEBI:8081

object_name: coronary atherosclerosis


subject: CHEBI:8081

object_name: Adverse reaction to adrenergic receptor antagonist


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: lung cancer


subject: PUBCHEM.COMPOUND:92043599

object_name: lung neoplasm


subject: PUBCHEM.COMPOUND:92043599

object_name: lung carcinoma


subject: PUBCHEM.COMPOUND:92043599

object_name: non-small cell lung carcinoma


subject: CHEBI:184381

subject_name: Bacitracin

object_name: sinusitis


subject: CHEBI:184381

object_name: Sinusitis, CTCAE


subject: UMLS:C2240391

subject_name: Herbal medicine (product)

object_name: Radiculopathy, Cervical


subject: UMLS:C2240391

object_name: Neck pain


subject: UMLS:C2240391

object_name: Neck Pain, CTCAE 5.0


subject: UMLS:C2240391

object_name: Neck Pain, CTCAE 3.0


subject: UMLS:C5909385

subject_name: HPV16 Vaccine

object_name: head and neck squamous cell carcinoma


subject: UMLS:C1541478

subject_name: Astuprotimut-R


subject: CHEBI:32322

subject_name: Nicoboxil

object_name: Acute low back pain


subject: CHEBI:46936

subject_name: Nonivamide


subject: PUBCHEM.COMPOUND:44144829

subject_name: Finalgon


subject: UMLS:C3491265

object_name: eosinophilic esophagitis


subject: UMLS:C3491265

object_name: Eosinophilic infiltration of the esophagus


subject: UMLS:C2362561

subject_name: Gluten

object_name: irritable bowel syndrome


subject: UMLS:C2827346

subject_name: wheat gluten extract


subject: UNII:1QC36BHI6S

subject_name: DEUPIRFENIDONE

object_name: interstitial lung disease 1


subject: UNII:1QC36BHI6S

object_name: interstitial lung disease 2


subject: DRUGBANK:DB19056

subject_name: Deupirfenidone


subject: DRUGBANK:DB19056


subject: UMLS:C4329325

subject_name: Anti-GITR Agonistic Monoclonal Antibody BMS-986156

object_name: Metastatic Malignant Solid Neoplasm


subject: UMLS:C4329325

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C4329325

object_name: Metastatic carcinoma to liver


subject: UMLS:C4329325

object_name: Metastatic Carcinoma in the Lung


subject: UMLS:C4329325

object_name: Metastatic Malignant Neoplasm in the Thoracic Cavity


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: DRUGBANK:DB15803

subject_name: Dendritic cells vaccine

object_name: Leptomeningeal Neoplasms


subject: DRUGBANK:DB15803

object_name: triple-negative breast carcinoma


subject: DRUGBANK:DB15803

object_name: Triple-Negative Breast Cancer Finding


subject: DRUGBANK:DB15803

object_name: HER2 positive breast carcinoma


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Advanced Sarcoma


subject: UNII:KXG2PJ551I

object_name: High Grade Sarcoma


subject: UNII:KXG2PJ551I

object_name: leiomyosarcoma


subject: UNII:KXG2PJ551I

object_name: Childhood Leiomyosarcoma


subject: UNII:KXG2PJ551I

object_name: Adult Leiomyosarcoma


subject: UNII:KXG2PJ551I

object_name: myxofibrosarcoma


subject: UNII:KXG2PJ551I

object_name: undifferentiated pleomorphic sarcoma


subject: UNII:KXG2PJ551I

object_name: Childhood Undifferentiated Pleomorphic Sarcoma


subject: UNII:KXG2PJ551I

object_name: dedifferentiated liposarcoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C4526670

subject_name: CSF1R Inhibitor DCC-3014

object_name: malignant soft tissue neoplasm


subject: UMLS:C4526670

object_name: sarcoma


subject: UMLS:C4526670


subject: UMLS:C4526670


subject: UMLS:C4526670


subject: UMLS:C4526670


subject: UMLS:C4526670


subject: UMLS:C4526670


subject: UMLS:C4526670


subject: UMLS:C4526670


subject: UMLS:C4526670


subject: UNII:9J765S329G

subject_name: L-Thyroxine sodium salt pentahydrate

object_name: Compensated hypothyroidism


subject: CHEBI:6447

subject_name: levothyroxine sodium hydrate


subject: UMLS:C0079691

subject_name: Levothroid


subject: CHEBI:63005

subject_name: Sodium nitrate

object_name: nasopharyngeal carcinoma


subject: CHEBI:63005

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: nephrolithiasis, calcium oxalate


subject: UMLS:C0013227

object_name: nephrolithiasis


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UNII:O880NM097T

subject_name: Avacopan

object_name: electrocardiography


subject: PUBCHEM.COMPOUND:137796979

object_name: Chronic Kidney Disease, CTCAE


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Recurrent Non-Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:2767

object_name: T-Cell Lymphoma


subject: CHEBI:41879

subject_name: Dexamethasone


subject: UMLS:C0733688


subject: UMLS:C0733688


subject: UMLS:C0733688

object_name: NK/T-cell lymphoma, nasal and nasal-type


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:32660

subject_name: asparaginase


subject: CHEBI:32660


subject: UMLS:C2684108

subject_name: Estradiol Vaginal Ring

object_name: Menopause present (finding)


subject: UMLS:C2684108

object_name: Menopause


subject: UNII:6N79I7X5II

subject_name: VALEMETOSTAT TOSYLATE

object_name: Advanced Malignant Solid Neoplasm


subject: UMLS:C5238968

subject_name: Valemetostat Tosylate


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Early Stage Breast Carcinoma


subject: CHEBI:16796

subject_name: Melatonin


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: UMLS:C3537249

subject_name: D Vitamin


subject: CHEBI:6801

subject_name: Metformin

object_name: Intertrochanteric Fractures


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Unresectable Malignant Solid Neoplasm


subject: CHEBI:231614

subject_name: Nivolumab


subject: UMLS:C2346820


subject: UMLS:C4684824

subject_name: Polyamine Analogue SBP-101

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C4684824

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C4684824

object_name: Stage IV Pancreatic Cancer AJCC v6 and v7


subject: UMLS:C4684824

object_name: stage IV pancreatic cancer


subject: UNII:05HYK3CV9N

subject_name: Linperlisib

object_name: lymphoma, non-Hodgkin, familial


subject: UNII:05HYK3CV9N

object_name: non-Hodgkin lymphoma


subject: UNII:05HYK3CV9N

object_name: Adult Non-Hodgkin Lymphoma


subject: UNII:05HYK3CV9N

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: Encounter due to hormone replacement therapy


subject: CHEBI:6413

subject_name: Letrozole

object_name: female breast carcinoma


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: cardiomyopathy


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: ocular cicatricial pemphigoid


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0006217

subject_name: bromelains

object_name: Acute cough


subject: CHEBI:5801

subject_name: Hydroxychloroquine

object_name: Immunosuppression


subject: CHEBI:5801

object_name: Decreased Immunologic Activity [PE]


subject: CHEBI:5801

object_name: Rheumatism


subject: CHEBI:39585

subject_name: Carbidopa

object_name: diabetic neuropathy


subject: PUBCHEM.COMPOUND:521372

subject_name: Cannabidiol


subject: CHEBI:149509

object_name: autosomal dominant polycystic kidney disease


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:91464

object_name: core binding factor acute myeloid leukemia


subject: CHEBI:63452

subject_name: Midostaurin


subject: CHEBI:42111

subject_name: D-Lactic acid

object_name: Asteatosis cutis


subject: CHEBI:16411

subject_name: Indoleacetic acid


subject: CHEBI:78320

subject_name: Lactic acid


subject: PR:000001024

subject_name: neural cell adhesion molecule 1

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0108754

subject_name: CD56 Antigens


subject: UNII:FR2W015BG1

object_name: diabetic kidney disease


subject: UMLS:C2981824


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Proprioceptive Disorders


subject: CHEBI:41879

object_name: balance; distorted


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:6456


subject: CHEBI:6931

subject_name: Midazolam

object_name: arteriosclerosis disorder


subject: CHEBI:6931

object_name: atherosclerosis


subject: PUBCHEM.COMPOUND:25476

subject_name: Angiotensina II

object_name: systemic inflammatory response syndrome


subject: CHEBI:2719

subject_name: Angiotensin II


subject: PR:000036009

subject_name: angiotensin II


subject: UMLS:C5400662

subject_name: Therapeutic Angiotensin II


subject: CHEBI:17650

subject_name: Hydrocortisone

object_name: Shock


subject: CHEBI:17650


subject: CHEBI:28645

subject_name: FRUCTOSE

object_name: hypertriglyceridemia


subject: CHEBI:28645

object_name: Hypertriglyceridemia, CTCAE


subject: CHEBI:28645

object_name: Abdominal obesity


subject: CHEBI:28645

object_name: Truncal obesity


subject: CHEBI:48095

subject_name: keto-D-fructose


subject: CHEBI:48095


subject: CHEBI:48095


subject: CHEBI:48095


subject: UMLS:C5417763

subject_name: Ziverel

object_name: esophagitis


subject: UMLS:C5417763

object_name: Acute esophagitis


subject: CHEBI:15365

subject_name: Aspirin

object_name: complication


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: Rett syndrome


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: PUBCHEM.COMPOUND:46783403

subject_name: Rifaximin

object_name: hepatitis B


subject: CHEBI:60802

subject_name: ropivacaine

object_name: Femoroacetabular impingement


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5848866

object_name: urothelial carcinoma


subject: UMLS:C5848866

object_name: transitional cell carcinoma


subject: CHEBI:9150

subject_name: Simvastatin

object_name: cirrhotic cardiomyopathy


subject: CHEBI:9150

object_name: acute kidney failure


subject: CHEBI:9150

object_name: Acute Kidney Injury, CTCAE


subject: CHEBI:9150

object_name: Decompensated cirrhosis of liver


subject: CHEBI:9150

object_name: Left Ventricular Diastolic Dysfunction, CTCAE


subject: CHEBI:9150

object_name: Left ventricular diastolic dysfunction


subject: UMLS:C4305754

object_name: inflammatory bowel disease


subject: UMLS:C5400007


subject: UMLS:C0718234

subject_name: Acthar

object_name: uveitis


subject: UMLS:C0718234

object_name: Uveitis, CTCAE


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: lupus erythematosus


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:59204

subject_name: Carbetocin

object_name: delivery (history)


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin


subject: UMLS:C0592155

subject_name: Syntocinon


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin

object_name: Mantle cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Adult Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Marginal zone lymphoma recurrent


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Adult Diffuse Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Adult Diffuse Mixed Cell Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Adult Diffuse Small Cleaved Cell Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: nodal marginal zone B-cell lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent Adult Immunoblastic Lymphoma


subject: PUBCHEM.COMPOUND:43805

object_name: Adult T-cell lymphoma/leukaemia recurrent


subject: PUBCHEM.COMPOUND:43805

object_name: Waldenstrom macroglobulinemia


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:177871

subject_name: brequinar sodium


subject: UMLS:C0877869


subject: CHEBI:4653

subject_name: Dipyridamole


subject: CHEBI:9150

subject_name: Simvastatin

object_name: essential hypertension


subject: CHEBI:62088

subject_name: Metamizole

object_name: gastroenteritis


subject: CHEBI:28241

subject_name: Papaverine


subject: UNII:AVK0I6HY2U

subject_name: Abaloparatide

object_name: Fracture of odontoid process


subject: CHEBI:74820

subject_name: Ser-Pro

object_name: hypertension


subject: CHEBI:74820

object_name: Hypertension, CTCAE


subject: PR:000016275

subject_name: trefoil factor 2


subject: PR:000016275


subject: UniProtKB:Q03404

subject_name: TFF2_MOUSE Trefoil factor 2 (sprot)


subject: UniProtKB:Q03404


subject: CHEBI:74061

subject_name: Ile-Arg


subject: CHEBI:74061


subject: CHEBI:49666

subject_name: iridium atom


subject: CHEBI:49666


subject: PR:000009064

subject_name: insulin receptor


subject: PR:000009064


subject: CHEBI:3732

subject_name: Clarithromycin

object_name: prostate carcinoma


subject: CHEBI:3732

object_name: prostate cancer


subject: CHEBI:70839

subject_name: Dasatinib

object_name: malignant mesothelioma


subject: CHEBI:190514


subject: CHEBI:49375


subject: CHEMBL.COMPOUND:CHEMBL1743030

subject_name: ICRUCUMAB

object_name: rectal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743030

object_name: rectal cancer


subject: CHEMBL.COMPOUND:CHEMBL1743030

object_name: Childhood Rectal Carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743030

object_name: colon carcinoma


subject: CHEMBL.COMPOUND:CHEMBL1743030

object_name: colorectal cancer


subject: CHEMBL.COMPOUND:CHEMBL1743030

object_name: colon cancer


subject: UMLS:C2698155

subject_name: Icrucumab


subject: UMLS:C2698155


subject: UMLS:C2698155


subject: UMLS:C2698155


subject: UMLS:C2698155


subject: UMLS:C2698155


subject: UNII:D99YVK4L0X

subject_name: Ramucirumab


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UNII:D99YVK4L0X


subject: UMLS:C1721684

subject_name: lexatumumab


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: UMLS:C1721684


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: primary mediastinal large B-cell lymphoma


subject: GTOPDB:9592

object_name: Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UNII:AG9MHG098Z

subject_name: Zanubrutinib


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: unspecified adult solid tumor, protocol specific


subject: GTOPDB:9592

object_name: endometrial cancer


subject: GTOPDB:9592

object_name: uterine corpus cancer


subject: GTOPDB:9592

object_name: endometrial carcinoma


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:32262

subject_name: Trimetazidine hydrochloride

object_name: diabetic cardiomyopathy


subject: CHEBI:32262

object_name: type 2 diabetes mellitus


subject: CHEBI:94789

subject_name: Trimetazidine


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450


subject: UMLS:C5963450

object_name: primary peritoneal carcinoma


subject: UMLS:C5963450

object_name: Primary Peritoneal Cancer


subject: UMLS:C5963450

object_name: fallopian tube carcinoma


subject: UMLS:C5963450

object_name: fallopian tube cancer


subject: UMLS:C0392938

subject_name: zoledronate

object_name: primitive neuroectodermal tumor


subject: UMLS:C0392938

object_name: Myelodysplasia


subject: UMLS:C0392938

object_name: Adult Myelodysplastic Syndrome


subject: UMLS:C0392938

object_name: childhood myelodysplastic syndrome


subject: UMLS:C0392938

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C0392938

object_name: acute lymphoblastic leukemia


subject: UMLS:C0392938

object_name: myeloproliferative syndrome


subject: UMLS:C0392938

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C0392938

object_name: acute myeloid leukemia


subject: UMLS:C0392938

object_name: lymphoma, non-Hodgkin, familial


subject: UMLS:C0392938

object_name: non-Hodgkin lymphoma


subject: UMLS:C0392938

object_name: Adult Non-Hodgkin Lymphoma


subject: UMLS:C0392938

object_name: Childhood Non-Hodgkin Lymphoma


subject: UMLS:C0392938

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C0392938

object_name: rhabdomyosarcoma


subject: UMLS:C0392938

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C0392938

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C0392938

object_name: Hodgkin Disease


subject: UMLS:C0392938

object_name: Adult Hodgkin Lymphoma


subject: UMLS:C0392938

object_name: Childhood Hodgkin Lymphoma


subject: UMLS:C0392938

object_name: Ewing sarcoma


subject: UMLS:C0392938

object_name: pediatric osteosarcoma


subject: UMLS:C0392938

object_name: Osteosarcoma


subject: CHEBI:46557

subject_name: Zoledronic acid

object_name: primitive neuroectodermal tumor


subject: CHEBI:46557

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:46557

object_name: childhood myelodysplastic syndrome


subject: CHEBI:46557

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:46557

object_name: myeloproliferative syndrome


subject: CHEBI:46557

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:46557

object_name: acute myeloid leukemia


subject: CHEBI:46557

object_name: lymphoma, non-Hodgkin, familial


subject: CHEBI:46557

object_name: Adult Non-Hodgkin Lymphoma


subject: CHEBI:46557

object_name: Childhood Non-Hodgkin Lymphoma


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:46557


subject: CHEBI:7772

subject_name: omeprazole

object_name: Critical Illness


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:83501

subject_name: Acesulfame

object_name: type 2 diabetes mellitus


subject: CHEBI:83501

object_name: Diabetes


subject: CHEBI:83501

object_name: pregnancy related


subject: CHEBI:83501

object_name: fetal growth restriction


subject: CHEBI:82431

subject_name: Cyclamate


subject: CHEBI:82431


subject: CHEBI:82431


subject: CHEBI:82431


subject: PUBCHEM.COMPOUND:18704444

subject_name: Assugrin


subject: PUBCHEM.COMPOUND:18704444


subject: PUBCHEM.COMPOUND:18704444


subject: PUBCHEM.COMPOUND:18704444


subject: CHEBI:15964

subject_name: CYCLAMIC ACID


subject: CHEBI:15964


subject: CHEBI:15964


subject: CHEBI:15964


subject: MESH:D003494

subject_name: Cyclamates


subject: MESH:D003494


subject: MESH:D003494


subject: MESH:D003494


subject: CHEBI:32111

subject_name: Saccharin


subject: CHEBI:32111


subject: CHEBI:32111


subject: CHEBI:32111


subject: CHEBI:195544

subject_name: Aspartame


subject: CHEBI:195544

object_name: diabetes mellitus


subject: CHEBI:195544


subject: CHEBI:195544


subject: UMLS:C0003999

subject_name: aspartame


subject: UMLS:C0003999


subject: UMLS:C0003999


subject: UMLS:C0003999


subject: CHEBI:187232

object_name: Headache


subject: CHEBI:187232

object_name: Headache, CTCAE


subject: CHEBI:27595


subject: CHEBI:27595


subject: CHEBI:57404

subject_name: Enzaprost F


subject: CHEBI:57404


subject: CHEBI:15553

subject_name: Dinoprost


subject: CHEBI:15553


subject: CHEMBL.COMPOUND:CHEMBL4297823

object_name: cancer


subject: CHEMBL.COMPOUND:CHEMBL4297823

object_name: neoplasm


subject: UMLS:C0967625


subject: UMLS:C0967625


subject: UMLS:C1321600

subject_name: Silver nitrate stain

object_name: Malignant pleural effusion


subject: CHEBI:32130

subject_name: Silver nitrate


subject: UMLS:C1161347

subject_name: Argentum nitricum, silver nitrate


subject: UMLS:C4053607


subject: UMLS:C4053607


subject: UMLS:C4053607

object_name: Secondary malignant neoplasm of lung


subject: CHEBI:6801

subject_name: Metformin

object_name: Muscle weakness or atrophy


subject: UNII:19J3781LPM

subject_name: Itacitinib

object_name: chronic graft versus host disease


subject: CHEBI:9168

subject_name: Sirolimus

object_name: Insulin Sensitivity


subject: CHEBI:177609

subject_name: Tariquidar

object_name: adrenal cortex neoplasm


subject: UMLS:C0910984


subject: UNII:82JB1524Q6

subject_name: Ombrabulin

object_name: Childhood Solid Neoplasm


subject: UNII:82JB1524Q6

object_name: Adult Solid Neoplasm


subject: UNII:82JB1524Q6

object_name: Solid Neoplasm


subject: UMLS:C0910081


subject: UMLS:C0910081


subject: UMLS:C0910081


subject: CHEBI:3699

subject_name: Cimetidine

object_name: bacterial infectious disease


subject: PUBCHEM.COMPOUND:3062

subject_name: Cogoxin


subject: CHEBI:145795


subject: CHEBI:4551

subject_name: Digoxin


subject: PUBCHEM.COMPOUND:135512673

subject_name: Rifampicin


subject: HMDB:HMDB0015179

subject_name: Rifampin


subject: UNII:VFC23V742Z

subject_name: dynorphin (1-13)

object_name: substance withdrawal syndrome


subject: UNII:VFC23V742Z

object_name: opiate dependence


subject: UMLS:C0058841


subject: UMLS:C0058841


subject: UMLS:C5227687

object_name: Hyperoxalaemia


subject: UMLS:C2756587

subject_name: soy

object_name: prostate carcinoma


subject: UMLS:C2756587

object_name: prostate cancer


subject: UMLS:C1697820

subject_name: soy - non-drug agent


subject: UMLS:C1697820


subject: CHEBI:228346

object_name: generalized anxiety disorder


subject: CHEBI:32278

subject_name: Urapidil

object_name: Acute Stroke


subject: CHEBI:32278

object_name: cerebrovascular disorder


subject: UNII:Z3867B9SQP

subject_name: Indantadol

object_name: Cough


subject: UNII:Z3867B9SQP

object_name: Cough, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL3707400

subject_name: INDANTADOL


subject: CHEMBL.COMPOUND:CHEMBL3707400


subject: UNII:3XPI7EG4W8

subject_name: patritumab deruxtecan

object_name: Metastatic Adult Malignant Neoplasm in the Brain


subject: UMLS:C4527158


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: B-cell non-Hodgkin lymphoma


subject: CHEBI:63716

object_name: B-cell neoplasm


subject: PUBCHEM.COMPOUND:64987


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:63625


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: nonpapillary renal cell carcinoma


subject: UNII:4EQZ6YO2HI

object_name: clear cell renal carcinoma


subject: UNII:4EQZ6YO2HI

object_name: Stage IV Renal Cell Cancer


subject: UMLS:C1530450

subject_name: AMG 162


subject: UMLS:C1530450


subject: UMLS:C1530450


subject: UNII:98BSN6N516

subject_name: Rogaratinib

object_name: Locally Advanced Gastrointestinal Stromal Tumor


subject: UNII:98BSN6N516

object_name: Metastatic Gastrointestinal Stromal Tumor


subject: UNII:98BSN6N516

object_name: Locally Advanced Sarcoma


subject: UNII:98BSN6N516

object_name: Stage IV Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8


subject: UNII:98BSN6N516

object_name: Stage III Gastric and Omental Gastrointestinal Stromal Tumor AJCC v8


subject: UNII:98BSN6N516

object_name: Stage IV Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8


subject: UNII:98BSN6N516

object_name: Stage III Small Intestinal, Esophageal, Colorectal, Mesenteric, and Peritoneal Gastrointestinal Stromal Tumor AJCC v8


subject: UNII:98BSN6N516

object_name: Metastatic sarcoma


subject: CHEBI:33380

subject_name: thulium atom

object_name: Dust mite allergy


subject: CHEBI:19226


subject: CHEBI:74861

subject_name: Thr-Met


subject: CHEBI:55460

subject_name: trimellityl group


subject: CHEBI:30703

subject_name: Tetrathiomolybdate


subject: UMLS:C3166394

subject_name: Tm antigen


subject: PR:000002105

subject_name: thrombomodulin


subject: CHEBI:195558

subject_name: Entrectinib

object_name: primary brain neoplasm


subject: CHEBI:195558

object_name: neuroendocrine neoplasm


subject: CHEBI:195558

object_name: pancreatic neoplasm


subject: CHEBI:195558

object_name: exocrine pancreatic carcinoma


subject: CHEBI:195558

object_name: malignant pancreatic neoplasm


subject: CHEBI:195558

object_name: head and neck neoplasm


subject: CHEBI:195558

object_name: anaplastic large cell lymphoma


subject: CHEBI:195558

object_name: salivary gland cancer


subject: CHEBI:195558

object_name: thyroid gland papillary carcinoma


subject: CHEBI:195558

object_name: colorectal cancer


subject: CHEBI:195558

object_name: colorectal carcinoma


subject: CHEBI:195558

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:195558

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:195558

object_name: clear cell renal carcinoma


subject: CHEBI:195558

object_name: renal cell adenocarcinoma


subject: CHEBI:195558

object_name: renal cell carcinoma


subject: CHEBI:195558

object_name: cholangiocarcinoma


subject: CHEBI:195558

object_name: ovarian cancer


subject: CHEBI:195558

object_name: ovarian neoplasm


subject: CHEBI:195558

object_name: ovarian carcinoma


subject: CHEBI:195558

object_name: malignant soft tissue neoplasm


subject: CHEBI:195558

object_name: sarcoma


subject: UMLS:C5198622

object_name: ventilator-associated pneumonia


subject: CHEBI:39867

subject_name: Valproic acid

object_name: bipolar II disorder


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: bipolar I disorder


subject: CHEBI:6367


subject: CHEBI:30145

subject_name: lithium atom


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: CHEBI:49713

subject_name: Lithium cation


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C4727552

subject_name: ALK Inhibitor WX-0593

object_name: non-small cell lung carcinoma


subject: PR:000004930

subject_name: calcineurin-binding protein cabin-1

object_name: hematopoietic and lymphoid system neoplasm


subject: UMLS:C1562036

subject_name: Calcineurin inhibitor


subject: UNII:19J3781LPM

subject_name: Itacitinib


subject: CHEBI:184023

subject_name: Argininosuccinic acid

object_name: Premature birth


subject: CHEBI:184023

object_name: preeclampsia


subject: PR:000004321

subject_name: arylsulfatase A


subject: PR:000004321


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: thymoma


subject: UNII:KXG2PJ551I

object_name: thymus neoplasm


subject: UNII:KXG2PJ551I

object_name: type C thymoma


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: pharynx neoplasm


subject: UNII:PQX0D8J21J

object_name: laryngeal neoplasm


subject: UNII:PQX0D8J21J

object_name: mouth neoplasm


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:50858

subject_name: corticosteroid

object_name: Behcet disease


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: CHEBI:68579

subject_name: Rivaroxaban


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: primary biliary cholangitis


subject: UNII:4F4X42SYQ6

object_name: Fatigue, CTCAE 5.0


subject: UNII:4F4X42SYQ6

object_name: Fatigue


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:46662

subject_name: mineral

object_name: cancer


subject: CHEBI:46662

object_name: neoplasm


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: skin melanoma


subject: CHEBI:85164


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Gallbladder cancer stage II


subject: CHEBI:175901

object_name: Stage II Gallbladder Cancer AJCC v6


subject: CHEBI:175901

object_name: Stage II Gallbladder Cancer AJCC v7


subject: CHEBI:231347

subject_name: Triapine


subject: CHEBI:231347


subject: CHEBI:231347

object_name: Stage II Gallbladder Cancer AJCC v8


subject: CHEBI:231347


subject: CHEBI:231347

object_name: Stage IVB Gallbladder Cancer AJCC v8


subject: CHEBI:231347

object_name: Stage IVB Gallbladder Cancer AJCC v7


subject: CHEBI:231347

object_name: Stage IVA Gallbladder Cancer AJCC v8


subject: CHEBI:231347

object_name: Stage IVA Gallbladder Cancer AJCC v7


subject: CHEBI:231347

object_name: stage IVA gallbladder cancer


subject: CHEBI:231347

object_name: Stage IIIB Gallbladder Cancer AJCC v8


subject: CHEBI:231347

object_name: Stage IIIB Gallbladder Cancer AJCC v7


subject: CHEBI:231347

object_name: stage IIIA gallbladder cancer


subject: CHEBI:231347

object_name: Stage IIIA Gallbladder Cancer AJCC v7


subject: CHEBI:231347

object_name: Stage IIIA Gallbladder Cancer AJCC v8


subject: UMLS:C5708954

object_name: mild neurocognitive disorder


subject: UMLS:C5708954

object_name: mild cognitive impairment


subject: PUBCHEM.COMPOUND:3685

object_name: refractory anemia with excess blasts in transformation


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: Secondary Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: UMLS:C4054033

subject_name: Suvemcitug

object_name: metastatic colorectal cancer


subject: CHEBI:221840

object_name: leukemia


subject: CHEBI:221840

object_name: childhood leukemia


subject: PUBCHEM.COMPOUND:4616292


subject: PUBCHEM.COMPOUND:4616292


subject: CHEBI:131168

subject_name: Afuresertib

object_name: non-small cell lung carcinoma


subject: CHEBI:131168

object_name: cervical cancer


subject: CHEBI:131168

object_name: cervical carcinoma


subject: CHEBI:131168

object_name: carcinoma of esophagus


subject: CHEBI:131168

object_name: esophageal cancer


subject: CHEBI:131168

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:131168

object_name: neoplasm of esophagus


subject: CHEBI:131168

object_name: endometrial cancer


subject: CHEBI:131168

object_name: uterine corpus cancer


subject: CHEBI:131168

object_name: endometrial carcinoma


subject: GTOPDB:12990

subject_name: sintilimab


subject: GTOPDB:12990


subject: GTOPDB:12990


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: CHEMBL.COMPOUND:CHEMBL4297829


subject: UMLS:C4329335

subject_name: IBI 308


subject: UMLS:C4329335


subject: UMLS:C4329335


subject: CHEBI:15365

subject_name: Aspirin

object_name: Uncontrolled asthma


subject: UMLS:C4079744

object_name: type 2 diabetes mellitus


subject: UMLS:C5556499

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C5556499

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C5556499

object_name: sarcoma


subject: UMLS:C5556499

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C5556499

object_name: soft tissue sarcoma


subject: UMLS:C5556499

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5205034


subject: UMLS:C5205034


subject: UMLS:C5205034


subject: UMLS:C5205034


subject: UMLS:C5205034


subject: UMLS:C5205034


subject: UMLS:C1522140

object_name: digestive system cancer


subject: UMLS:C0042210

subject_name: Vaccines

object_name: rabies


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Stage IV Esophageal Cancer AJCC v6


subject: CHEBI:4672

object_name: Stage IV Esophageal Cancer AJCC v7